Unpacking Averages: Assessing the Products Included in FDA's Voluntary Malfunction Summary Reporting Program
At the end of 2022, FDA published a draft guidance on Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers. The draft guidance explains several aspects of the VMSR Program, including FDA’s approach to determining… more